Antimalarial treatment with artemisinin combination therapy in Africa

British Medical Journal

Volumn 331, Issue 7519, 2005, Pages 706-707

  Malenga, Grace ^a   Palmer, Ayo ^b   Staedke, Sarah ^c   Kazadi, Walter ^d,e   Mutabingwa, Theonest ^f,g   Ansah, Evelyn ^h,i   Barnes, Karen I ^j   Whitty, Christopher J M ^k  

^a Malaria Alert Centre   (Malawi)

^b Centre for Innovation Against Malaria   (Gambia)

^c MAKERERE UNIVERSITY   (Uganda)

^d West African Network for Monitoring Antimalarial Treatment II

^e Malaria Consortium   (Ghana)

^f East African Network for Monitoring Antimalarial Treatment

^g Muheza Designated District Hospital   (Tanzania)

^h Health Services

ⁱ Department of Infectious and Tropical Diseases   (United Kingdom)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

^k LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE;

AFRICA; CAUSE OF DEATH; DISEASE TRANSMISSION; DRUG COST; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HUMAN; INFECTION RISK; MALARIA; MONOTHERAPY; MORBIDITY; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 26244465090     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.331.7519.706     Document Type: Editorial

References (10)

1. Snow RW, Guerra CA, Moor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005;434:214-7.
2. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N. Artesunate combinations for treatment of malaria: meta-analysis. International Artemisinin Study Group. Lancet 2004;363:9-17.
3. Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, et al. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 2005;365:1474-80.
4. Muheki C, McIntyre D, Barnes KI. Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health 2004;9:959-66.
5. Arrow KJ, Panosian C, Gelband H, Eds. Saving lives, buying time: economics, of malaria drugs in an age of resistance. Washington, DC: Institute of Medicine, 2004.
6. Zurovac D, Ndhlovu M, Rowe AK, Maner DH, Thea DM, Snow RW. Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study. BMJ 2005;331:734-7.
7. Amexo M, Tolhurst R, Barnish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet 2004;364:1896-8.
8. Reyburn H, Mbatia R, Drakeley C, Carneiro I, Mwakasungula E, Mwerinde O, et al. Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: prospective study. BMJ 2004;329:1212-5.
9. Marsh VM, Mutemi WM, Willetts A, Bayah K, Were S, Ross A, et al. Improving malaria home treatment by training drug retailers in rural Kenya. Trop Med Int Health 2004;9:451-60.
10. Staedke SG, Mpimbaza A, Kamya MR, Nzarubara BK, Dorsey G, Rosenthal PJ. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. Lancet 2004;364:1950-7.